Table of Contents Table of Contents
Previous Page  16 / 52 Next Page
Information
Show Menu
Previous Page 16 / 52 Next Page
Page Background

Subestudios

Checkmate 141: NIVOLUMAB EN RECURRENTE / METASTÁSICO

. Poster Discussion.

.